Interactive discussion: what are the implications of SGLT2 inhibition for CV risk reduction in a multi-risk patient population?
Event:
ESC Congress 2016
Topic:
Diabetes management
Session:
SGLT2 inhibition in the management of CV risk & T2DM: ask the experts
